Overview of therapeutic targets in management of dementia.

Rohit Malik, Sunishtha Kalra, Saurabh Bhatia, Ahmed Al Harrasi, Govind Singh, Syam Mohan, Hafiz A Makeen, Mohammed Albratty, Abdulkarim Meraya, Bojlul Bahar, Murtaza M Tambuwala

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2022;152():113168

PMID: 35701303

Abstract

Dementia is defined as a gradual cognitive impairment that interferes with everyday tasks, and is a leading cause of dependency, disability, and mortality. According to the current scenario, millions of individuals worldwide have dementia. This review provides with an overview of dementia before moving on to its subtypes (neurodegenerative and non-neurodegenerative) and pathophysiology. It also discusses the incidence and severity of dementia, focusing on Alzheimer's disease with its different hypotheses such as Aβ cascade hypothesis, Tau hypothesis, inflammatory hypothesis, cholinergic and oxidative stress hypothesis. Alzheimer's disease is the most common type and a progressive neurodegenerative illness distinct by neuronal loss and resulting cognitive impairment, leading to dementia. Alzheimer's disease (AD) is considered the most familiar neurodegenerative dementias that affect mostly older population. There are still no disease-modifying therapies available for any dementias at this time, but there are various methods for lowering the risk to dementia patients by using suitable diagnostic and evaluation methods. Thereafter, the management and treatment of primary risk elements of dementia are reviewed. Finally, the future perspectives of dementia (AD) focusing on the impact of the new treatment are discussed.

Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Address: Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India.; School of Health Sciences, University of Petroleum and Energy Studies, Dehradun, Uttarakhand, India; Natural & Medical Sciences Research Centre, University of Nizwa, Birkat Al Mauz, Oman.; Natural & Medical Sciences Research Centre, University of Nizwa, Birkat Al Mauz, Oman.; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India. Electronic address: [email protected].; School of Health Sciences, University of Petroleum and Energy Studies, Dehradun, Uttarakhand, India; Substance Abuse and Toxicology Research Centre, Jazan University, Jazan, Saudi Arabia.; Pharmacy Practice Research Unit, Clinical Pharmacy Department, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.; Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.; Substance Abuse and Toxicology Research Centre, Jazan University, Jazan, Saudi Arabia.; Nutrition Sciences and Applied Food Safety Studies, Research Centre for Global Development, School of Sport & Health Sciences, University of Central Lancashire, Preston, UK.; School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine, UK. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.